NCT03113539View on ClinicalTrials.gov

Low-dose Gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

May 30, 2019

Conditions
Ascendant Aortic Aneurysm
Interventions
OTHER

Modified Low-dose, EKG-gated CT without contrast for the evaluation of aortic aneurysm

"On the same day, the subject will do :~1. Modified low-dose, EKG-gated CT without contrast~2. Usual high-dose, EKG-gated CT with contrast~Comparing aortic diameters from the two protocols."

Trial Locations (1)

J1H5N4

Sherbrooke University Hospital, Sherbrooke

All Listed Sponsors
lead

Université de Sherbrooke

OTHER

NCT03113539 - Low-dose Gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm. | Biotech Hunter | Biotech Hunter